RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1016%2Fj.jff.2022.105397
https://w3id.org/ripe/ripe-kg/work/10.1016%2Fj.jff.2022.105397
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1016%2Fj.jff.2022.105397The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson's disease: A double-blind, placebo-controlled, randomized controlled trial |
prism:doi |
10.1016/j.jff.2022.105397 |
ripekg:work/10.1016%2Fj.jff.2022.105397The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson's disease: A double-blind, placebo-controlled, randomized controlled trial |
dcterms:title |
The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson's disease: A double-blind, placebo-controlled, randomized controlled trial |
ripekg:work/10.1016%2Fj.jff.2022.105397The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson's disease: A double-blind, placebo-controlled, randomized controlled trial |
rdf:type |
node1 |
ripekg:work/10.1016%2Fj.jff.2022.105397The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson's disease: A double-blind, placebo-controlled, randomized controlled trial |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1016%2Fj.jff.2022.105397The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson's disease: A double-blind, placebo-controlled, randomized controlled trial |
rdf:type |
rdfs:Resource |
ripekg:work/10.1016%2Fj.jff.2022.105397The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson's disease: A double-blind, placebo-controlled, randomized controlled trial |
rdf:type |
owl:Thing |
ripekg:work/10.1016%2Fj.jff.2022.105397The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson's disease: A double-blind, placebo-controlled, randomized controlled trial |
rdf:type |
prov:Entity |
ripekg:work/10.1016%2Fj.jff.2022.105397The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson's disease: A double-blind, placebo-controlled, randomized controlled trial |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1016%2Fj.jff.2022.105397The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson's disease: A double-blind, placebo-controlled, randomized controlled trial |
owl:sameAs |
https://semopenalex.org/work/W4313442714 |
ripekg:work/10.1136%2Fbmjopen-2024-093167Effect of saffron supplementation on Parkinson’s disease: a study protocol for a triple-blind randomised controlled clinical trial |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.jff.2022.105397The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson's disease: A double-blind, placebo-controlled, randomized controlled trial |
ripekg:work/10.1136%2Fbmjopen-2024-093167Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.jff.2022.105397The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson's disease: A double-blind, placebo-controlled, randomized controlled trial |